PACB – pacific biosciences of california, inc. (US:NASDAQ)
Stock Stats
News
Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now [Yahoo! Finance]
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at UBS Group AG to a "hold" rating.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $7.00 to $6.00. They now have a "sector outperform" rating on the stock.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
Form SC 13G PACIFIC BIOSCIENCES OF Filed by: EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE)
Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: MADRONE CAPITAL PARTNERS, LLC
Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: VANGUARD GROUP INC
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 11
Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.